<DOC>
	<DOCNO>NCT01670552</DOCNO>
	<brief_summary>The purpose study evaluate safety association one anti-inflammatory one gastroprotective agent compare one anti-inflammatory one gastroprotective agent patient acute chronic osteoarticular inflammation .</brief_summary>
	<brief_title>Evaluation Two Therapies Treatment Osteoarticular Inflammation Dyspeptic Patients</brief_title>
	<detailed_description>- Double-blind , randomize , multicenter - Experiment duration : 14 day - 03 visit - Evaluate safety association one anti-inflammatory one gastroprotective compare association one anti-inflammatory one gastroprotective agent patient acute chronic osteoarticular inflammation - Adverse event evaluation</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Nimesulide</mesh_term>
	<criteria>Adults male female age â‰¥ 18 year old ; Comply purpose procedure study sign date Informed Consent . Acute chronic osteoarticular injury need antiinflammatory period 14 day . Pregnant woman , woman childbearing age use effective contraception intend become pregnant study period History peptic ulcer gastric surgery ; Use Nonsteroidal antiinflammatory ( NSAIDs ) , aspirin , proton pump inhibitor ( PPIs ) , H2 blocker antacid past 7 day ; Contraindication use NSAIDs PPIs ; Renal hepatic impairment ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>